Serotonergic versus nonserotonergic dorsal raphe projection neurons: Differential participation in reward circuitry

Cell Reports

Volumn 8, Issue 6, 2014, Pages 1857-1869

  McDevitt, Ross A ^a   Tiran Cappello, Alix ^a,b   Shen, Hui ^a   Balderas, Israela ^a,c   Britt, Jonathan P ^a,f   Marino, Rosa A M ^a   Chung, Stephanie L ^a   Richie, Christopher T ^a   Harvey, Brandon K ^a   Bonci, Antonello ^a,d,e  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITÉ DE LYON   (France)

^c INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^d UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; 4 AMINOBUTYRIC ACID RECEPTOR; AMPHETAMINE; DOPAMINE; FENFLURAMINE; SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CELL POPULATION; CELL TYPE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DORSAL RAPHE NUCLEUS; FUNCTIONAL ANATOMY; MALE; MOUSE; NERVE CELL; NERVE CELL STIMULATION; NERVE PROJECTION; NONHUMAN; NONSEROTONINERGIC NERVE CELL; OPTOGENETICS; REINFORCEMENT; REWARD; SEROTONINERGIC NERVE CELL; VENTRAL TEGMENTUM; ANIMAL; C57BL MOUSE; DRUG EFFECTS; FEMALE; METABOLISM; TRANSGENIC MOUSE;

AMPHETAMINE; ANIMALS; DOPAMINE; DOPAMINERGIC NEURONS; DORSAL RAPHE NUCLEUS; FEMALE; FENFLURAMINE; GABAERGIC NEURONS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SEROTONERGIC NEURONS; SEROTONIN; VENTRAL TEGMENTAL AREA;

EID: 84907408797     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.08.037     Document Type: Article

References (55)

1. Adamantidis A.R., Zhang F., Aravanis A.M., Deisseroth K., de Lecea L. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 2007, 450:420-424.
2. Bang S.J., Commons K.G. Forebrain GABAergic projections from the dorsal raphe nucleus identified by using GAD67-GFP knock-in mice. J. Comp. Neurol. 2012, 520:4157-4167.
3. Boye S.M., Rompré P.P. Mesencephalic substrate of reward: axonal connections. J. Neurosci. 1996, 16:3511-3520.
4. Britt J.P., Benaliouad F., McDevitt R.A., Stuber G.D., Wise R.A., Bonci A. Synaptic and behavioral profile of multiple glutamatergic inputs to the nucleus accumbens. Neuron 2012, 76:790-803.
5. Britt J.P., McDevitt R.A., Bonci A. Use of channelrhodopsin for activation of CNS neurons. Current Protocols in Neuroscience 2012, John Wiley & Sons, Somerset, NJ, Unit2.16. C.R. Gerfen, A. Holmes, D. Sibley, P. Skolnick, S. Wray (Eds.).
6. Cador M., Ahmed S.H., Koob G.F., Le Moal M., Stinus L. Corticotropin-releasing factor induces a place aversion independent of its neuroendocrine role. Brain Res. 1992, 597:304-309.
7. Challis C., Boulden J., Veerakumar A., Espallergues J., Vassoler F.M., Pierce R.C., Beck S.G., Berton O. Raphe GABAergic neurons mediate the acquisition of avoidance after social defeat. J Neurosci 2013, 33:13978-13988. 13988a.
8. Commons K.G. Locally collateralizing glutamate neurons in the dorsal raphe nucleus responsive to substance P contain vesicular glutamate transporter 3 (VGLUT3). J. Chem. Neuroanat. 2009, 38:273-281.
9. Corbett D., Wise R.A. Intracranial self-stimulation in relation to the ascending noradrenergic fiber systems of the pontine tegmentum and caudal midbrain: a moveable electrode mapping study. Brain Res. 1979, 177:423-436.
10. Dougalis A.G., Matthews G.A., Bishop M.W., Brischoux F., Kobayashi K., Ungless M.A. Functional properties of dopamine neurons and co-expression of vasoactive intestinal polypeptide in the dorsal raphe nucleus and ventro-lateral periaqueductal grey. Eur. J. Neurosci. 2012, 36:3322-3332.
11. Elliott P.J. Place aversion induced by the substance P analogue, dimethyl-C7, is not state dependent: implication of substance P in aversion. Exp. Brain Res. 1988, 73:354-356.
12. Fletcher P.J., Ming Z.H., Higgins G.A. Conditioned place preference induced by microinjection of 8-OH-DPAT into the dorsal or median raphe nucleus. Psychopharmacology (Berl.) 1993, 113:31-36.
13. Fouriezos G., Wise R.A. Pimozide-induced extinction of intracranial self-stimulation: response patterns rule out motor or performance deficits. Brain Res. 1976, 103:377-380.
14. Geisler S., Derst C., Veh R.W., Zahm D.S. Glutamatergic afferents of the ventral tegmental area in the rat. J. Neurosci. 2007, 27:5730-5743.
15. Götestam K.G., Andersson B.E. Self-administration of amphetamine analogues in rats. Pharmacol. Biochem. Behav. 1975, 3:229-233.
16. Griffiths R.R., Winger G., Brady J.V., Snell J.D. Comparison of behavior maintained by infusions of eight phenylethylamines in baboons. Psychopharmacology (Berl.) 1976, 50:251-258.
17. Hioki H., Nakamura H., Ma Y.F., Konno M., Hayakawa T., Nakamura K.C., Fujiyama F., Kaneko T. Vesicular glutamate transporter 3-expressing nonserotonergic projection neurons constitute a subregion in the rat midbrain raphe nuclei. J. Comp. Neurol. 2010, 518:668-686.
18. Inaba K., Mizuhiki T., Setogawa T., Toda K., Richmond B.J., Shidara M. Neurons in monkey dorsal raphe nucleus code beginning and progress of step-by-step schedule, reward expectation, and amount of reward outcome in the reward schedule task. J. Neurosci. 2013, 33:3477-3491.
19. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 1992, 72:165-229.
20. Kempadoo K.A., Tourino C., Cho S.L., Magnani F., Leinninger G.M., Stuber G.D., Zhang F., Myers M.G., Deisseroth K., de Lecea L., Bonci A. Hypothalamic neurotensin projections promote reward by enhancing glutamate transmission in the VTA. J. Neurosci. 2013, 33:7618-7626.
21. Lammel S., Lim B.K., Ran C., Huang K.W., Betley M.J., Tye K.M., Deisseroth K., Malenka R.C. Input-specific control of reward and aversion in the ventral tegmental area. Nature 2012, 491:212-217.
22. Lee H.S., Kim M.A., Valentino R.J., Waterhouse B.D. Glutamatergic afferent projections to the dorsal raphe nucleus of the rat. Brain Res. 2003, 963:57-71.
23. Lindeberg J., Usoskin D., Bengtsson H., Gustafsson A., Kylberg A., Söderström S., Ebendal T. Transgenic expression of Cre recombinase from the tyrosine hydroxylase locus. Genesis 2004, 40:67-73.
24. Liu Z.H., Ikemoto S. The midbrain raphe nuclei mediate primary reinforcement via GABA(A) receptors. Eur. J. Neurosci. 2007, 25:735-743.
25. Liu Y., Jiang Y., Si Y., Kim J.Y., Chen Z.F., Rao Y. Molecular regulation of sexual preference revealed by genetic studies of 5-HT in the brains of male mice. Nature 2011, 472:95-99.
26. Liu Z., Zhou J., Li Y., Hu F., Lu Y., Ma M., Feng Q., Zhang J.E., Wang D., Zeng J., et al. Dorsal raphe neurons signal reward through 5-HT and glutamate. Neuron 2014, 81:1360-1374.
27. Lu J., Jhou T.C., Saper C.B. Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter. J. Neurosci. 2006, 26:193-202.
28. Madisen L., Zwingman T.A., Sunkin S.M., Oh S.W., Zariwala H.A., Gu H., Ng L.L., Palmiter R.D., Hawrylycz M.J., Jones A.R., et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 2010, 13:133-140.
29. Margolis E.B., Lock H., Hjelmstad G.O., Fields H.L. The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons?. J. Physiol. 2006, 577:907-924.
30. Margules D.L. Noradrenergic rather than serotonergic basis of reward in the dorsal tegmentum. J. Comp. Physiol. Psychol. 1969, 67:32-35.
31. Mathews T.A., Fedele D.E., Coppelli F.M., Avila A.M., Murphy D.L., Andrews A.M. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. J. Neurosci. Methods 2004, 140:169-181.
32. Nakamura K., Matsumoto M., Hikosaka O. Reward-dependent modulation of neuronal activity in the primate dorsal raphe nucleus. J. Neurosci. 2008, 28:5331-5343.
33. Nowak L.G., Bullier J. Axons, but not cell bodies, are activated by electrical stimulation in cortical gray matter. I. Evidence from chronaxie measurements. Exp. Brain Res. 1998, 118:477-488.
34. Phillipson O.T. Afferent projections to the ventral tegmental area of Tsai and interfascicular nucleus: a horseradish peroxidase study in the rat. J. Comp. Neurol. 1979, 187:117-143.
35. Rompré P.P., Miliaressis E. Pontine and mesencephalic substrates of self-stimulation. Brain Res. 1985, 359:246-259.
36. Rompré P.P., Miliaressis E. Behavioral determination of refractory periods of the brainstem substrates of self-stimulation. Behav. Brain Res. 1987, 23:205-219.
37. Rothman R.B., Baumann M.H. Appetite suppressants, cardiac valve disease and combination pharmacotherapy. Am. J. Ther. 2009, 16:354-364.
38. Scott M.M., Wylie C.J., Lerch J.K., Murphy R., Lobur K., Herlitze S., Jiang W., Conlon R.A., Strowbridge B.W., Deneris E.S. A genetic approach to access serotonin neurons for in vivo and in vitro studies. Proc. Natl. Acad. Sci. USA 2005, 102:16472-16477.
39. Sharp T., Bramwell S.R., Clark D., Grahame-Smith D.G. In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity. J. Neurochem. 1989, 53:234-240.
40. Simon H., Le Moal M., Cardo B. Intracranial self-stimulation from the dorsal raphe nucleus of the rat: effects of the injection of para-chlorophenylalanine and of alpha-methylparatyrosine. Behav. Biol. 1976, 16:353-364.
41. Stuber G.D., Sparta D.R., Stamatakis A.M., van Leeuwen W.A., Hardjoprajitno J.E., Cho S., Tye K.M., Kempadoo K.A., Zhang F., Deisseroth K., Bonci A. Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking. Nature 2011, 475:377-380.
42. Tye K.M., Deisseroth K. Optogenetic investigation of neural circuits underlying brain disease in animal models. Nat. Rev. Neurosci. 2012, 13:251-266.
43. Valentino R.J., Commons K.G. Peptides that fine-tune the serotonin system. Neuropeptides 2005, 39:1-8.
44. Van Der Kooy D., Fibiger H.C., Phillips A.G. An analysis of dorsal and median raphe self-stimulation: effects of parachlorophenylalanine. Pharmacol. Biochem. Behav. 1978, 8:441-445.
45. Vasudeva R.K., Lin R.C., Simpson K.L., Waterhouse B.D. Functional organization of the dorsal raphe efferent system with special consideration of nitrergic cell groups. J. Chem. Neuroanat. 2011, 41:281-293.
46. Vertes R.P. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J. Comp. Neurol. 1991, 313:643-668.
47. Vong L., Ye C., Yang Z., Choi B., Chua S., Lowell B.B. Leptin action on GABAergic neurons prevents obesity and reduces inhibitory tone to POMC neurons. Neuron 2011, 71:142-154.
48. Wanat M.J., Hopf F.W., Stuber G.D., Phillips P.E., Bonci A. Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih. J. Physiol. 2008, 586:2157-2170.
49. Watabe-Uchida M., Zhu L., Ogawa S.K., Vamanrao A., Uchida N. Whole-brain mapping of direct inputs to midbrain dopamine neurons. Neuron 2012, 74:858-873.
50. Wise R.A. Dopamine, learning and motivation. Nat. Rev. Neurosci. 2004, 5:483-494.
51. Witten I.B., Steinberg E.E., Lee S.Y., Davidson T.J., Zalocusky K.A., Brodsky M., Yizhar O., Cho S.L., Gong S., Ramakrishnan C., et al. Recombinase-driver rat lines: tools, techniques, and optogenetic application to dopamine-mediated reinforcement. Neuron 2011, 72:721-733.
52. Wu Q., Clark M.S., Palmiter R.D. Deciphering a neuronal circuit that mediates appetite. Nature 2012, 483:594-597.
53. Zawertailo L.A., Busto U., Kaplan H.L., Sellers E.M. Comparative abuse liability of sertraline, alprazolam, and dextroamphetamine in humans. J. Clin. Psychopharmacol. 1995, 15:117-124.
54. Zhang T.A., Placzek A.N., Dani J.A. In vitro identification and electrophysiological characterization of dopamine neurons in the ventral tegmental area. Neuropharmacology 2010, 59:431-436.
55. Zhuang X., Masson J., Gingrich J.A., Rayport S., Hen R. Targeted gene expression in dopamine and serotonin neurons of the mouse brain. J. Neurosci. Methods 2005, 143:27-32.